Glucocorticoid-induced p11 over-expression and chromatin remodeling: A novel molecular mechanism of traumatic stress?

Medical Hypotheses

Volumn 76, Issue 6, 2011, Pages 774-777

  Zhang, Lei ^a   Li, He ^a   Hu, Xianzhang ^a   Li, Xiao Xia ^a   Smerin, Stanley ^a   Ursano, Robert ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; MIFEPRISTONE;

ARTICLE; BRAIN FUNCTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DEPRESSION; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; P11 GENE; POSTTRAUMATIC STRESS DISORDER; PROMOTER REGION; TRANSCRIPTION INITIATION;

ANNEXIN A2; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; S100 PROTEINS; STRESS DISORDERS, POST-TRAUMATIC;

EUKARYOTA;

EID: 79955721449     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.015     Document Type: Article

References (41)

1. Cohen H., Zohar J., Gidron Y., et al. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 2006, 59:1208-1218.
2. de Kloet C.S., Vermetten E., Heijnen C.J., Geuze E., Lentjes E.G., Westenberg H.G. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology 2007, 32:215-226.
3. Belda X., Rotllant D., Fuentes S., Delgado R., Nadal R., Armario A. Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 2008, 1148:165-173.
4. Yehuda R., Kahana B., Binder-Brynes K., Southwick S.M., Mason J.W., Giller E.L. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am j psychiatry 1995, 152:982-986.
5. Lindauer R.J., Olff M., van Meijel E.P., Carlier I.V., Gersons B.P. Cortisol, learning, memory, and attention in relation to smaller hippocampal volume in police officers with posttraumatic stress disorder. Biol Psychiatry 2006, 59:171-177.
6. Pfeffer C.R., Altemus M., Heo M., Jiang H. Salivary cortisol, psychopathology in children bereaved by the september 11, Terror attacks. Biol Psychiatry 2001, 61(2007):957-965.
7. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 2001, 933:265-277.
8. Yehuda R., Golier J.A., Yang R.K., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 2004, 55:1110-1116.
9. Pollard I., White B.M., Bassett J.R., Cairncross K.D. Plasma glucocorticoid elevation and desynchronization of the estrous cycle following unpredictable stress in the rat. Behav biol 1975, 14:103-108.
10. Li X., Han F., Liu D., Shi Y. Changes of Bax, Bcl-2 and apoptosis in hippocampus in the rat model of post-traumatic stress disorder. Neurological research 2010, 32(6):579-586.
11. Amador-Arjona A., Delgado-Morales R., Belda X., et al. Susceptibility to stress in transgenic mice overexpressing TrkC, a model of panic disorder. Journal of psychiatric research 2010, 44:157-167.
12. Yau J.L., Noble J., Seckl J.R. Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci Lett 2001, 309:141-144.
13. Meaney M.J., Diorio J., Francis D., et al. Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. J Neurosci 2000, 20:3926-3935.
14. Zhang L., Li H., Su T.P., et al. P11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter. Neuroscience 2008, 153:1126-1134.
15. Svenningsson P., Chergui K., Rachleff I., et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
16. Caspi Y., Saroff O., Suleimani N., Klein E. Trauma exposure and posttraumatic reactions in a community sample of Bedouin members of the Israel Defense Forces. Depress Anxiety 2008, 25:700-707.
17. Ginzburg K., Ein-Dor T., Solomon Z., disorder Comorbidity of posttraumatic stress anxiety and depression: a 20-year longitudinal study of war veterans. J affect disord 2010, 123:249-257.
18. Perry M., Chalkley R. Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin. A novel model for the biological role of histone acetylation. J biol chem 1982, 257:7336-7347.
19. Nightingale K.P., Wellinger R.E., Sogo J.M., Becker P.B. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin. EMBO J 1998, 17:2865-2876.
20. Urnov F.D., Wolffe A.P. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001, 20:2991-3006.
21. Barnes P.J., Adcock I.M., Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005, 25:552-563.
22. Adcock I.M., Ito K., Barnes P.J. Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 2004, 1:247-254.
23. Dokmanovic M., Clarke C., Marks P.A. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007, 5:981-989.
24. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370:737-749.
25. Longworth M.S., Laimins L.A. Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src. Oncogene 2006, 25:4495-4500.
26. Sengupta N., Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004, 93:57-67.
27. Valenzuela-Fernandez A., Cabrero J.R., Serrador J.M., Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008, 18:291-297.
28. Weinmann A.S., Farnham P.J. Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods (San Diego) Calif 2002, 26:37-47.
29. van der Laan S., Sarabdjitsingh R.A., Van Batenburg M.F., et al. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J Neurochem 2008, 106:2515-2523.
30. Morsink M.C., Joels M., Sarabdjitsingh R.A., Meijer O.C., De Kloet E.R., Datson N.A. The dynamic pattern of glucocorticoid receptor-mediated transcriptional responses in neuronal PC12 cells. J Neurochem 2006, 99:1282-1298.
31. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
32. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
33. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996, 382:319-324.
34. Schoneveld O.J., Gaemers I.C., Lamers W.H. Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 2004, 1680:114-128.
35. Pelaia G., Vatrella A., Cuda G., Maselli R., Marsico S.A. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 2003, 72:1549-1561.
36. Ki S.H., Cho I.J., Choi D.W., Kim S.G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol Cell Biol 2005, 25:4150-4165.
37. P. J. Skene, R. S. Illingworth, S. Webb, et al., Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state, Mol cell 37, 457-468.
38. S. Gupta, S. Y. Kim, S. Artis, et al., Histone methylation regulates memory formation, J Neurosci 30, 3589-3599.
39. Sweatt J.D. Epigenetics and cognitive aging. Science 2010, 328:701-702.
40. Tsolaki M., Eleftheriou M., Karavida N. Alzheimer's dementia and post-traumatic stress disorder differences and similarities in neuroimaging. Hell J Nucl Med 2009, 12:41-46.
41. Simonini M.V., Camargo L.M., Dong E., et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 2006, 103:1587-1592.